Spruce Biosciences (SPRB) Prepaid Assets (2019 - 2026)
Spruce Biosciences (SPRB) posted quarterly Prepaid Assets of $864000.0 for Q1 2026, down 70.2% year-over-year from $2.9 million in Q1 2025, and down 69.72% quarter-over-quarter from $2.9 million in Q4 2025.
Spruce Biosciences (SPRB) Prepaid Assets (2019 - 2026) Analysis & Trends
Spruce Biosciences (SPRB) has reported Prepaid Assets for 8 consecutive years, with $864000.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Prepaid Assets fell 70.2% year-over-year to $864000.0; the TTM figure through Mar 2026 stood at $864000.0 (down 70.2% YoY), while the FY2025 annual figure was $2.9 million, down 10.2% from the prior year.
- Prepaid Assets fell to $864000.0 in Q1 2026 per SPRB's latest filing, from $2.9 million in the prior quarter.
- Across five years, Prepaid Assets topped out at $3.9 million in Q4 2023 and bottomed at $206000.0 in Q2 2023.
- Historically, Prepaid Assets has averaged $1.7 million across 5 years, with a median of $1.2 million in 2022.
- Annual changes were most pronounced in 2022 — Prepaid Assets tumbled 87.9% — and 2024, when it surged 1209.71%.
- Spruce Biosciences' Prepaid Assets stood at $1.2 million in 2022, then jumped by 220.07% to $3.9 million in 2023, then dropped by 18.03% to $3.2 million in 2024, then retreated by 10.2% to $2.9 million in 2025, then plunged by 69.72% to $864000.0 in 2026.
- Business Quant data shows SPRB's Prepaid Assets at $864000.0 in Q1 2026, $2.9 million in Q4 2025, and $932000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Spruce Biosciences | 119.20 Mn | 119.20 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 4.63 Mn |
| Mar 31, 2026 | 864,000.00 |
| Dec 31, 2025 | 2.85 Mn |
| Sep 30, 2025 | 932,000.00 |
| Jun 30, 2025 | 2.70 Mn |
| Mar 31, 2025 | 2.90 Mn |
| Dec 31, 2024 | 3.18 Mn |
| Sep 30, 2024 | 860,000.00 |
| Jun 30, 2024 | 2.70 Mn |
| Mar 31, 2024 | 1.61 Mn |
| Dec 31, 2023 | 3.88 Mn |
| Sep 30, 2023 | 419,000.00 |
| Jun 30, 2023 | 206,000.00 |
| Mar 31, 2023 | 253,000.00 |
| Dec 31, 2022 | 1.21 Mn |
| Sep 30, 2022 | 2.79 Mn |
| Jun 30, 2022 | 390,000.00 |
| Mar 31, 2022 | 325,000.00 |
| Dec 31, 2021 | 2.53 Mn |
| Sep 30, 2021 | 301,000.00 |